CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company
Annovis Bio, Inc.
Sign in to watch- Ticker
- ANVS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262540421
- Phone
- 484-875-3192
- Business address
- 101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
- Former names
- QR Pharma, Inc.
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4/A Grant or award Director acquired 1,990 shares (grant or award)
- 4/A Other acquisition Director acquired 0 shares (other)
- 4/A Grant or award Director acquired 163,880 shares (grant or award)
- 4/A Grant or award President and CEO acquired 40,970 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 820 shares (grant or award)
- 4/A Other acquisition Director acquired 0 shares (other)
- 4 Grant or award Director acquired 824 shares (grant or award)
Page 7 of 16 · 315 filings